A Study to Evaluate the Microbiology, Safety and Tolerability of C16G2 Dental Strip Application
Status:
Completed
Trial end date:
2017-04-05
Target enrollment:
Participant gender:
Summary
Single-blind study to evaluate whether C16G2 Strip administered in multiple doses can
effectively kill the bacteria in the oral cavity that cause dental caries..
Phase:
Phase 2
Details
Lead Sponsor:
Armata Pharmaceuticals, Inc. C3 Jian, LLC
Collaborators:
Agility Clinical, Inc. E Squared Trials and Registries, Inc. Vantage Data Designs, Inc.